Torben Rixecker

6PUBLICATIONS
29CO-AUTHORS
Haematological tumoursEpidemiological modellingPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 24, 2026
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Onur Cetin, Igor Kos, Evi Regitz

|Dec 08, 2025
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Onur Cetin, Igor Kos, Evi Regitz

|Oct 06, 2025
Tidal volume and mortality during extracorporeal membrane oxygenation for acute respiratory distress syndrome: a multicenter observational cohort study.

Torben M Rixecker, Jeannine L Kühnle, Johannes Herrmann

|Sep 28, 2024
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients.

Sylvia Zöphel, Nadja Küchler, Johanna Jansky

|Jan 29, 2021
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.

Lorenz Thurner, Natalie Fadle, Jörg Thomas Bittenbring

|Jul 25, 2020
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy.

Torben Rixecker, Vadim Lesan, Manfred Ahlgrimm

Pageof 1

Frequent Collaborators

4 joint publications

Lorenz Thurner

3 joint publications

Onur Cetin

3 joint publications

Eva C Schwarz

3 joint publications

Johanna Jansky